Suppr超能文献

非典型变异和重排在毛细胞白血病中。

Non-canonical variants and rearrangements in hairy cell leukemia.

机构信息

Cancer Molecular Diagnostics, St. James's Hospital, Dublin, D08 W9RT, Ireland.

出版信息

Oncol Res. 2024 Aug 23;32(9):1423-1427. doi: 10.32604/or.2024.051218. eCollection 2024.

Abstract

Hairy cell leukemia (HCL) is an uncommon mature B-cell malignancy characterized by a typical morphology, immunophenotype, and clinical profile. The vast majority of HCL patients harbor the canonical V600E mutation which has become a rationalized target of the subsequently deregulated RAS-RAF-MEK-MAPK signaling pathway in HCL patients who have relapsed or who are refractory to front-line therapy. However, several HCL patients with a classical phenotype display non-canonical mutations or rearrangements. These include sequence variants within alternative exons and an oncogenic fusion with the gene. Care must be taken in the molecular diagnostic work-up of patients with typical HCL but without the V600E to include investigation of these uncommon mechanisms. Identification, functional characterization, and reporting of further such patients is likely to provide insights into the pathogenesis of HCL and enable rational selection of targeted inhibitors in such patients if required.

摘要

毛细胞白血病(HCL)是一种罕见的成熟 B 细胞恶性肿瘤,其特征为典型的形态学、免疫表型和临床特征。绝大多数 HCL 患者存在典型的 V600E 突变,这已成为 HCL 患者中随后失调的 RAS-RAF-MEK-MAPK 信号通路的合理靶点,这些患者复发或对一线治疗耐药。然而,一些具有典型表型的 HCL 患者表现出非典型突变或重排。这些包括在替代外显子内的序列变异和与 基因的致癌融合。在对具有典型 HCL 但无 V600E 的患者进行分子诊断时,必须注意包括对这些罕见机制的调查。进一步鉴定、功能特征描述和报告此类患者可能有助于深入了解 HCL 的发病机制,并在需要时为这些患者选择靶向抑制剂提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbf2/11361905/d426373cdd09/OncolRes-32-51218-f001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验